Power Semiconductors

Report: Intel FPGA unit inches closer to sale

20 February 2025

Altera, the field programmable gate array (FPGA) division of Intel Corp., is moving closer to being sold, according to numerous reports.

Speculation is that Altera, which was officially made part of Intel in December of 2025, is up for sale as Intel seeks to refocus its product portfolio and divest itself of divisions that are no longer in its core business.

Intel already launched Altera as a standalone company in March of 2024 with a focus on FPGAs integrated with AI built into the fabric of the processors. Altera once again became the name of the standalone company after the name was retired when it was integrated into Intel.

Suitors

According to Bloomberg, Silver Lake Management is in exclusive negotiations to acquire a majority stake in Altera. The private equity firms Francisco Partners, Apollo Global Management and Bain Capital are also in the mix. Altera competitor Lattice Semiconductor is also rumored to be interested in acquiring the company.

However, Silver Lake may be the frontrunner, and talks are in the advanced stages. The exact stake remains undecided. Intel originally acquired Altera for $16.7 billion.

Another report from CNBC said that Intel originally planned to sell at least a minority stake in Altera when they spun it off into a standalone company. The move could give Intel several billions in cash as it struggles financially.

To contact the author of this article, email PBrown@globalspec.com


Powered by CR4, the Engineering Community

Discussion – 0 comments

By posting a comment you confirm that you have read and accept our Posting Rules and Terms of Use.
Engineering Newsletter Signup
Get the GlobalSpec
Stay up to date on:
Features the top stories, latest news, charts, insights and more on the end-to-end electronics value chain.
Advertisement
Weekly Newsletter
Get news, research, and analysis
on the Electronics industry in your
inbox every week - for FREE
Sign up for our FREE eNewsletter
Advertisement